Health

The empirical analysis of public sector investments and the health value created by the drugs selected for Medicare price negotiations provides a cost basis for the assessment of the maximum fair price.

By all accounts infection rates have ebbed. But were we good or were we lucky?

Dr. Ming Lin, and healthcare providers like him, are fighting to take back control of medicine from private equity firms that are gobbling up practices and facilities. Should Wall Street make life-and-death decisions based on the bottom line?

The principal threat to economic stability currently is the overhang of debt, both private and public.

Evidence sharply contradicts PhRMA’s contention that its member companies need unregulated drug prices to generate profits that they then reinvest in drug innovation.

Researchers find that the nation had become an outlier among other rich countries in mortality rates long before the pandemic – and that Americans are dying younger than their peers abroad.

In a harrowing new book, scholar Laura Katz Olson pulls back the curtain on a shadowy Wall Street threat that is taking over health care companies – and preying on human lives.

As women’s rights to make reproductive choices come under assault, historian John M. Riddle argues that abortion has been far more essential to human history than you might imagine.

An interview with INET Global Commissioner Winnie Byanyima

Former health insurance executive turned whistleblower and investigative journalist Wendell Potter discusses the many ways in which the private health insurance system of the US is not serving anyone well except the insurance companies’ owners

It’s time to prioritize mental well-being to avoid far-reaching economic and social consequences.

An interview with Dr. Ibrahim Mayaki, CEO of the African Union Development Agency (AUDA-NEPAD)

An interview with John Nkengasong, Director of Africa CDC, about how a coordinated response to COVID-19 in Africa has proven to be effective

Doctors and medical experts say private equity firms and profiteering corporations are putting American lives at risk and compromising the practice of medicine.

In this interview, Dr. Folashadé Soulé and Dr. Camilla Toulmin speak with Pr. Mzukisi Qobo. Pr Qobo is the Head of the Wits School of Governance, University of Witwatersrand, South Africa.